Online pharmacies that carry Wegovy: the facts before you search

The biggest misconception: that 'in stock' means 'legitimate'

Type the right words into a search engine and you will find dozens of sites claiming to carry Wegovy. Some are straightforwardly illegal. Others operate in a grey area, they run a brief online tick-box form, stamp it as a 'prescription', and dispatch whatever they have. Neither of these is what the law requires.

The misconception worth correcting first is this: availability is not the same as legitimacy. A site can have stock, a professional-looking storefront, and next-day delivery promises, and still be operating outside the UK's Human Medicines Regulations. The relevant question is not whether a pharmacy has Wegovy on its shelves, it is whether a GPhC-registered prescriber has personally reviewed your clinical information before a prescription is written for you.

Wegovy contains semaglutide, a GLP-1 receptor agonist that works by mimicking a gut hormone involved in appetite regulation and blood-sugar control, slowing gastric emptying and reducing how much you want to eat. The NHS medicines page for semaglutide sets out how the medicine works, its side effects, and who it may not be suitable for. That level of clinical nuance is exactly why a prescriber needs to assess you individually, stock availability is irrelevant if the medicine is not right for you.

What a regulated online pharmacy dispensing Wegovy must do

A pharmacy registered with the GPhC and dispensing a prescription-only medicine like Wegovy must, at minimum: collect enough clinical information to support a prescribing decision, have that information reviewed by a qualified prescriber, issue a legal prescription, and dispense from a registered premises. You can check any pharmacy's registration on the GPhC register in about thirty seconds, search by name or registration number. If a pharmacy is not listed there, do not order from it.

Beyond the bare minimum, the better services do more. At nume, every consultation is read by a GPhC-registered Independent Prescriber on the same day, a named clinician, not automated decision software. Identity and current weight are verified before a prescription is written. For more on what responsible clinical oversight looks like from our team, our clinical lead's profile sets this out.

Wegovy's licensed dosing pathway starts at 0.25 mg and escalates gradually through 0.5 mg, 1.0 mg, 1.7 mg and 2.4 mg, with each step requiring clinical confidence that the previous dose has been tolerated. In January 2026 the MHRA also approved a 7.2 mg maintenance dose, with a dedicated single-dose pen approved in April 2026 for adults with a BMI of 30 or above. That titration schedule is not optional; it exists because rushed dose increases carry a real risk of significant side effects, and a prescriber needs to be involved at each stage.

The supply chain matters as much as the stock

The MHRA has warned publicly, and repeatedly, about counterfeit weight-loss pens sold through online channels. In one 2025 enforcement operation alone, around 20 million doses of illegally traded weight-loss medicines worth roughly £45 million were seized, and the MHRA raided the UK's first known illicit manufacturing site for counterfeit tirzepatide pens. Fake pens have previously contained insulin rather than the labelled medicine, a risk that is genuinely life-threatening for people without diabetes.

A price that looks too good to be true usually is. For context, Eli Lilly raised Mounjaro's UK list price significantly from September 2025, and the private market for semaglutide (Wegovy) reflects real supply costs. If you want to buy Wegovy online through a legitimate route, legitimate private pricing typically runs into the hundreds of pounds per month by the time you include clinical oversight and dispensing. A site offering it at a fraction of that, or offering to supply it without a prescriber being involved, should be treated as a red flag. You can report suspected illegal sellers via the MHRA Yellow Card scheme.

For a straightforward overview of the Wegovy treatment itself, including eligibility and what the evidence shows, our Wegovy information page covers the clinical picture in full. If you are weighing up whether semaglutide is the right medicine for you compared with other options, the semaglutide overview is a useful starting point.

Eligibility for Wegovy through a private online pharmacy

The private licensing criteria for Wegovy are set by the medicine's UK marketing authorisation. Adults with a BMI of 30 or above, or 27 or above alongside at least one weight-related condition such as high blood pressure, high cholesterol, or obstructive sleep apnoea, may be eligible. Lower BMI thresholds can apply for people from certain ethnic backgrounds under UK clinical guidance. A BMI figure alone does not determine the outcome, a prescriber considers the full clinical picture, including other medicines you take and any conditions that would make Wegovy unsuitable.

On the NHS, Wegovy is available through specialist weight management services under NICE Technology Appraisal 875, but access is restricted and waiting lists are commonly long. People researching how to access treatment can find it helpful to read about Wegovy results alongside understanding what the clinical criteria actually involve, so expectations are grounded before a consultation takes place. Private online pharmacies registered with the GPhC offer an alternative route for people who meet the clinical criteria but cannot or prefer not to wait, and those who want to explore a Wegovy shop online should look for one that visibly lists its GPhC registration and named prescribers. That route still requires a real prescription from a real prescriber. If you would like to find out whether you are eligible, checking your eligibility through a free consultation is the right first step, and our Wegovy online page explains exactly how that process works at nume.